Carl F. Mauch
Investor Relations Contact at TCR2 THERAPEUTICS INC.
Carl F. Mauch active positions
| Companies | Position | Start | End |
|---|---|---|---|
| TCR2 THERAPEUTICS INC. | Investor Relations Contact | - | - |
| Public Communications Contact | - | - | |
| ITEOS THERAPEUTICS, INC. | Investor Relations Contact | - | - |
| Public Communications Contact | - | - | |
Stern Investor Relations, Inc.
 Stern Investor Relations, Inc. Investment ManagersFinance Stern Investor Relations, Inc. provides investor relations services to healthcare and biotechnology companies. The company was founded in 2009 and is headquartered in New York, NY. | Director/Board Member | 2015-12-31 | - |
Career history of Carl F. Mauch
Statistics
International
| United States | 4 |
Operational
| Public Communications Contact | 2 |
| Investor Relations Contact | 2 |
| Director/Board Member | 1 |
Sectoral
| Health Technology | 3 |
| Finance | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| ITEOS THERAPEUTICS, INC. | Health Technology |
| Private companies | 2 |
|---|---|
Stern Investor Relations, Inc.
Stern Investor Relations, Inc. Investment ManagersFinance Stern Investor Relations, Inc. provides investor relations services to healthcare and biotechnology companies. The company was founded in 2009 and is headquartered in New York, NY. | Finance |
TCR2 Therapeutics, Inc.
 TCR2 Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology TCR2 Therapeutics, Inc. is a clinical-stage cell therapy company, which engages in the development of biological drugs and engineering T-cells for cancer therapy. It is also involved in the research and collaboration with academic laboratories and industry partners in the field of T-cell immunology, cell therapy, gene editing, and process development. The company was founded by Patrick A. Baeuerle on May 29, 2015 and is headquartered in Cambridge, MA. | Health Technology |
- Stock Market
- Insiders
- Carl F. Mauch
- Experience
